Showing results (81-90 of 219) with videos related to
Sort By:
Pageof 22
Journal of Medical Economics|November 21, 2012
Healthcare resource usage of schizophrenia patients initiating long-acting injectable antipsychotics vs oralSteve Offord, Bruce Wong, Dario Mirski, et al.Plant Cell Reports|May 9, 2013
Ectopic expression of bacterial amylopullulanase enhances bioethanol production from maize grainHartinio N Nahampun, Chang Joo Lee, Jay-Lin Jane, et al.Advances in Therapy|August 12, 2010
Total costs and atrial fibrillation ablation success or failure in Medicare-aged patients in the United StatesMichael H Kim, Jay Lin, Charles Kreilick, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 13, 2006
Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndromeDavid A MacDougall, Anthony L Feliu, Stephen J Boccuzzi, et al.Biomacromolecules|May 9, 2006
Morphology and properties of soy protein and polylactide blendsJinwen Zhang, Long Jiang, Linyong Zhu, et al.The American Journal of Managed Care|March 20, 2018
Improving quality of care in oncology through healthcare payment reformLonnie Wen, Christine Divers, Melissa Lingohr-Smith, et al.Journal of Medical Economics|January 15, 2015
Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the USAlpesh Amin, Amanda Bruno, Jeffrey Trocio, et al.Journal of Agricultural and Food Chemistry|July 25, 2014
Effects of heat treatment and moisture contents on interactions between lauric acid and starch granulesFengdan Chang, Xiaowei He, Xiong Fu, et al.Journal of Medical Economics|August 2, 2017
Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitorsSteven Deitelzweig, W Richey Neuman, Melissa Lingohr-Smith, et al.Clinical Therapeutics|January 10, 2017
Using Health Care Claims Data to Assess the Prevalence of Hodgkin Lymphoma and Relapsed or Refractory Hodgkin Lymphoma in the United StatesJay Lin, Lisa R Siegartel, Melissa Lingohr-Smith, et al.Pageof 22